International Drug & Explosives Detection Firm IDenta To Sign Exclusive Development Agreement With French Agency - Vast Market Projected For Company's New Precursors Products.

JERUSALEM -- IDenta Corp. (Pink Sheets:IDTA.PK - News) today announced the company, through its representatives in France, IBTEC, will be signing an exclusive agreement to develop its new precursor products for MNCPC-MISSION NATIONALE DE CONTROLE DES PRECURSEURS CHEHIMIQUES. The announcement follows last week's presentation to The International Narcotics Control Board (INCB) of the United Nations concerning the crisis problem of drug manufacturing in Afghanistan.

"As far as we know, IDenta is the only company in the world that is developing products to address this huge need for precursor detectors," said IDTA CEO Yaacov Shoham. "In this industry all of the other companies have simply produced the same exact products year after year. IDenta is the only company that has maintained ongoing new product R&D which is the reason we are now at the forefront of the drug, precursor and explosive detection industry."

IDenta's new detector for acetic anhydride, the precursor for heroin, was very well received last Thursday at the Paris meeting of INCB and from that meeting, IBTEC, located in Villeurbanne, France, the company's French representatives, will be signing an exclusive agreement with the French agency, MNCPC. The new agreement will generate an immediate order for the new precursor detector, and includes research and development funding for IDenta to develop additional products for detecting precursors used to develop other drugs such as cocaine and methamphetamines. The new contacts from governments around the world, made during the U.N. conference, also open the door for greatly expanding the awareness of IDenta's other drug and explosive detection products.

IDenta's new precursor test devices are similar to those that the company is currently using to produce its drug and explosive detectors. They have a hard plastic casing that includes vials of chemical detectors and will be very easy and safe to use. As with all of IDenta's other products, they will be able to detect precursor chemicals immediately and positively from the field without further laboratory confirmation.

The international market for IDenta's precursors detectors will be primarily law enforcement agencies dealing with border patrols and customs, and by the special agencies in governments charged with the responsibility to find and detect precursors used to make illicit drugs. It is estimated the market for drug precursor products could potentially exceed millions of units per year.

Bulk pricing of IDenta's new precursor products has not been determined, but single units are expected to retail for approximately $5.00 U.S. dollars. The company is currently accepting advance orders for its precursor products and inquiries for the development of additional chemical detectors.

ABOUT IDENTA

Since 2003, IDenta Corporation has become recognized as a world-wide leader in the development of proprietary on-site drug, drug precursor and explosive detection kits. IDenta develops, manufactures and distributes products for the both professional and civil markets which consistently pass the highest qualifications and testing procedures of law enforcement and security agencies around the world. Information concerning IDenta's entire product line may be found at www.IDenta.biz

DISCLAIMER

Certain of the statements contained herein may be, within the meaning of the federal securities laws, "forward-looking statements" that are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking statements are based on management's expectations as of the date hereof, and the company does not undertake any responsibility to update any of these statements in the future.

For Investor Relations, lobbying interests or information concerning IDenta's products internationally or the development of new chemical detectors, contact: Yaacov Shoham, IDenta Corp., CEO, Tel: [phone], [e-mail];

For Investor Relations in the US, contact: Randy Jacobs, Corporate Spokesman, [e-mail], 1-800-316-9437;

For information about the Accutest[R] - IDenta products in the US, please contact: Mr. Eyal Golan, COO, JANT PHARMACAL CORPORATION, 16255 Ventura Blvd. #505, Encino, CA 91436, Toll Free: 800-676-5565, http://www.accutest.net.